Active Ingredient(s):Sitagliptin + Simvastatin FDA Approved: * October 7, 2011 Pharm Company: *MERCK SHARP DOHME Category:Diabetes
Sitagliptin/simvastatin, sold under the brand name Juvisync, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes and hypercholesterolemia. It contains sitagliptin and simvastatin. Sitagliptin is a dipeptidyl peptidase-4 inhibitor and simvastatin is an HMG-CoA reductase inhibitor. These two disorders commonly occur in patients at the same time, and have been typically treated with administration of these two drugs in separate tablets. The com...
* May have multiple approval dates, manufacturers, or labelers.